0.9549

1.07% 0.0101

After Hours: .94 -0.0149 -1.56%

Mira Pharmaceuticals Inc (MIRA)

Overview News Price History Discussions Forecast

Mira Pharmaceuticals Inc stock is traded at $0.9549, with a volume of 68,431. It is up +1.07% in the last 24 hours and down -4.51% over the past month. Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Previous Close:

$0.9448

Open:

$0.94

24h Volume:

68,431

Relative Volume:

0.53

Market Cap:

$40.13M

Revenue:

Net Income/Loss:

$-31.37M

P/E Ratio:

-0.664

EPS:

-1.438

Net Cash Flow:

$-4.23M

1W Performance:

+0.57%

1M Performance:

-4.51%

6M Performance:

-35.04%

1Y Performance:

-20.42%

1-Day Range:

$0.92

$0.9604

1-Week Range:

$0.92

$0.99

52-Week Range:

$0.90

$2.45

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name

Mira Pharmaceuticals Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - General (20)

Phone

813-369-5150

Address

1200 BRICKELL AVENUE, MIAMI

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

MIRA's Discussions on Twitter

Compare MIRA vs LLY, JNJ, ABBV, MRK, NVS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MIRA Mira Pharmaceuticals Inc	0.9549	39.77M	0	-31.37M	-4.23M	-1.438
LLY Lilly Eli Co	1,200.06	1.07T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	259.33	611.36B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	254.76	444.60B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	126.78	317.37B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	155.49	299.04B	54.66B	13.58B	16.05B	7.0171

Mira Pharmaceuticals Inc Stock (MIRA) Latest News

Jun 29, 2026

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Cloustonmoomoo - Moomoo

Jun 29, 2026

MIRA Pharmaceuticals, Inc.(NasdaqCM:MIRA) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

MIRA Pharmaceuticals, Inc.(NasdaqCM: MIRA) added to Russell 3000E Index - marketscreener.com

Jun 28, 2026

MIRA SEC FilingsMira Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2026

Jun 27, 2026

Price to earnings forward of MIRA Pharmaceuticals, Inc. – NASDAQ:MIRA - TradingView

Jun 27, 2026

Jun 26, 2026

Enterprise value to revenue forward of MIRA Pharmaceuticals, Inc. – NASDAQ:MIRA - TradingView

Jun 26, 2026

MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC - Black Hills Pioneer

Jun 26, 2026

MIRA Pharmaceuticals (NASDAQ:MIRA) Reports Positive Preclinical Data for Mira-55 in Chronic Inflammatory Pain - grafa.com

Jun 25, 2026

Mira Pharmaceuticals reports preclinical data on pain drug candidate - Investing.com

Jun 25, 2026

MIRA Pharmaceuticals Advances Mira-55 for Chronic Pain Relief - GuruFocus

Jun 25, 2026

Mira Pharmaceuticals reports preclinical data on pain drug candidate By Investing.com - Investing.com Australia

Jun 25, 2026

MIRA Unveils Differentiated Preclinical Data for Mira-55 - TipRanks

Jun 25, 2026

MIRA’s Mira-55 eases anxiety in preclinical tests, unlike THC - Stock Titan

Jun 25, 2026

MIRA reports preclinical Mira-55 data showing distinct mechanism, anxiolytic activity vs THC - TradingView

Jun 25, 2026

MIRA Pharmaceuticals (NASDAQ: MIRA) highlights differentiated Mira-55 preclinical profile vs. THC - Stock Titan

Jun 25, 2026

Jun 22, 2026